ANDA 74920, held by Teva. Clonazepam.
As of Nov 14, 2026, ANDA 74920 (Clonazepam), held by Teva, was first approved by FDA on Aug 4, 1998, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 4, 1998 | Original application | Approved |
| Clonazepam0.5MG · tablet;oral | Clonazepam | Discontinued |
| Clonazepam1MG · tablet;oral | Clonazepam | Discontinued |
| Clonazepam2MG · tablet;oral | Clonazepam | Discontinued |
| Apr 25, 2000 | Supplement 2Labeling | Approved | None posted |
| Aug 4, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
